Stage IV Childhood Large Cell Lymphoma Active Not Recruiting Phase 2 Trials for Alemtuzumab (DB00087)

IndicationStatusPhase
DBCOND0030017 (Stage IV Childhood Large Cell Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00040846Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesTreatment